| Upcoming events on PFIZER INC. |
|
| 01/28/21 | | Ex-dividend day for |
| 02/02/21 | | FY 2020 Earnings Release |
| 02/02/21 | 10:00am | | FY 2020 Earnings Call |
| 05/04/21 | | Q1 2021 Earnings Release (Projected) |
|
| Past events on PFIZER INC. |
|
| 01/12/21 | 10:00am | | JP Morgan Healthcare Conference |
| 12/07/20 | | American Society of Hematology Meeting |
| 11/18/20 | 09:50am | | Wolfe Virtual Healthcare Conference |
| 11/17/20 | | Spin off |
|
| Upcoming sector events for PFIZER INC. |
|
|
| |
|
| Past sector events for PFIZER INC. |
|
|
|
|
|
| Annual results | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 (e) |
Sales
M $ |
Released
Forecast
Spread | 48 851
48 399
0,93% | 52 824
52 891
-0,13% | 52 546
52 524
0,04% | 53 647
53 582
0,12% | 51 750
51 807
-0,11% |
48 425
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread | 22 880
20 437
12% | 20 309
20 776
-2,2% | 21 172
21 875
-3,2% | 21 814
21 615
0,92% | 21 097
22 824
-7,6% |
22 302
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | 17 723
17 769
-0,26% | 18 480
18 819
-1,8% | 19 468
19 859
-2,0% | 20 042
19 998
0,22% | 19 420
19 883
-2,3% |
17 923
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | 8 965
12 544
-29% | 8 351
11 125
-25% | 12 305
14 925
-18% | 11 885
16 386
-27% | 17 682
22 426
-21% |
13 153
|
Net income
M $ |
Released
Forecast
Spread | 7 745
9 766
-21% | 7 215
8 882
-19% | 21 308
11 574
84% | 11 153
14 121
-21% | 16 273
19 053
-15% |
19 798
|
EPS
$ |
Released
Forecast
Spread | 1,24
1,46
-15% | 1,17
1,36
-14% | 3,52
1,88
87% | 1,87
2,38
-21% | 2,87
3,40
-16% |
3,10
| | Announcement Date | 02/02/2016 | 01/31/2017 | 01/30/2018 | 01/29/2019 | 01/28/2020 | |
|
|
|
| Quarterly results | 2018 Q2 | 2018 Q3 | 2018 Q4 | 2019 Q1 | 2019 Q2 | 2019 Q3 | 2019 Q4 | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 (e) | 2021 Q1 (e) | 2021 Q2 (e) | 2021 Q3 (e) | 2021 Q4 (e) |
Sales
M $ |
Released
Forecast
Spread | 13 466
13 298
1,3% | 13 298
13 533
-1,7% | 13 976
13 929
0,34% | 13 118
13 012
0,82% | 13 264
13 430
-1,2% | 12 680
12 365
2,5% | 12 688
12 728
-0,31% | 12 028
11 743
2,4% | 11 801
11 553
2,1% | 12 131
12 298
-1,4% |
12 012
|
13 045
|
13 283
|
13 059
|
13 069
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread | 5 665
5 677
-0,21% | 5 517
5 439
1,4% | 4 917
4 629
6,2% | 6 061
5 672
6,9% | 5 763
5 640
2,2% | 5 426
4 475
21% | 3 826
4 218
-9,3% | 5 539
5 220
6,1% | 5 279
5 180
1,9% | 5 595
5 090
9,9% |
3 944
|
5 483
|
5 408
|
5 403
|
5 057
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | 5 224
5 279
-1,0% | 5 085
5 196
-2,1% | 4 459
4 356
2,4% | 5 636
5 148
9,5% | 5 352
4 961
7,9% | 5 013
4 058
24% | 3 418
3 819
-10% | 5 135
4 535
13% | 4 791
4 175
15% | 4 333
4 505
-3,8% |
3 722
|
4 999
|
4 999
|
4 999
|
4 999
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | 4 527
4 189
8,1% |
|
| 4 323
3 682
17% |
|
|
|
|
|
|
|
|
|
|
|
Net income
M $ |
Released
Forecast
Spread | 3 872
3 263
19% | 4 114
3 935
4,6% | -394
2 689
-115% | 3 884
3 539
9,7% | 5 046
3 658
38% | 7 680
3 245
137% | -337
3 241
-110% | 3 401
|
| 2 194
3 215
-32% |
3 376
|
|
|
|
|
EPS
$ |
Released
Forecast
Spread | 0,65
0,56
16% | 0,69
0,58
19% | -0,07
0,49
-114% | 0,68
0,60
13% | 0,89
0,65
38% | 1,36
0,53
158% | -0,06
0,53
-111% | 0,61
0,47
29% |
| 0,39
0,57
-32% |
0,34
|
|
|
|
| | Announcement Date | 07/31/2018 | 10/30/2018 | 01/29/2019 | 04/30/2019 | 07/29/2019 | 10/29/2019 | 01/28/2020 | 04/28/2020 | 07/28/2020 | 10/27/2020 | | | | | |
|
Financial data source
© 2021 S&P Global Market Intelligence
|
|
© 2021 Factset
|
|
|
|
REFILE-Pfizer forecasts 2021 earnings of $3 to $3.10 per share |
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
Previous period
